Clinical Pharmacology Protein Production Science 
Drug Discovery World
NOVEMBER 9, 2023
Peter O’Callaghan, PhD, Head of Expression System Sciences, Biologics and Licensing, Lonza, on: ‘Solve bispecific heavy-light chain mispairing with bYlok technology’. James Cooke, PhD, Associate Director, Bicycle Therapeutics, on: ‘Engineering bicyclic peptides for precision targeted medicine’.
Drug Discovery World
NOVEMBER 8, 2023
Kathrin Herbst, PhD, Director of Science & Business Development, Lightcast, on: ‘A new era of single-cell functional profiling for drug discovery’. David Mills, PhD, Senior Director, Preclinical Science, Ambrx, on: ‘Preclinical discovery of ARX622, a site-specific HER2-targeted TLR7 agonist immune-stimulatory antibody conjugate’.
Expert insights. Personalized for you.
130 
Let's personalize your content